32.Alosaimy S, Morrisette T, Lagnf AM, et al. Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii. Microbiol Spectr. 2022;10(5):e0047922. doi:10.1128/spectrum.00479-2...
2. Propose that the opinions of the consulting expert groupshould be considered in CER for specific Class III and IIbdevices; 3. For implants and Class III devices, clinical research shouldbe considered; 4. Require the CER to update the data obtained according toPMCF; ...
32.Alosaimy S, Morrisette T, Lagnf AM, et al. Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii. Microbiol Spectr. 2022;10(5):e0047922. doi:10.1128/spectrum.00479-22 33.IDWEEK 2022 -655 poster 34.IDWEEK 2022-633 poster 35....
Good afternoon Dr. Shields. First of all, I just want to say it was a great talk and thank you for having this interview with us. And so for the first question, you've conducted extensive research in the field ...
For data entry control, by each center was required to complete at least 95% of clinical forms to be included in the final analysis. All components of both primary and secondary endpoints were evaluated and adjudicated independently by at least two physicians (C.G. and A.B.). In case of...
Clinical research has shown this blend of Antarctic Krill Oil and Hyaluronic Acid can promote relief from joint discomfort. Move easier with greater flexibility! Wild Blueberry & Bilberry Antioxidants Boosts antioxidant defenses with extracts proven to help support circulation and blood vessel integrity....
the use of rapid diagnostic tests. And many of these new technologies are advancing the way we can practice in clinical medicine. So by continuing to develop new antibiotics to overcome known mechanisms of resistance and being able to detect them in clinical micro labs, this is ultimately going...
Megan Duff, Licensing Project Manager, has extensive project management experience in various areas of the clinical research industry. She has worked at a CRO, eCOA vendor, and COA licensor. Megan is focused on prioritizing safety and efficacy in subject-centered research through COAs. She guides...
Mutation-induced drug resistance is a significant challenge to the clinical treatment of many diseases, as structural changes in proteins can diminish drug efficacy. Understanding how mutations affect protein-ligand binding affinities is crucial for developing new drugs and therapies. However, the lack ...
Drug-resistant tuberculosis (DR-TB) continues to pose a significant global health challenge.The current guidelines for the programmatic management of DR-TB in India and are in line with the WHO Guidelines.Several ongoing clinical studies aim to evaluate the efficacy and safety of these new drugs ...